MTOR and breast carcinoma: miR‐142‐3p was found to alter paclitaxel resistance by targeting recombinant G protein beta 2 (GNB2), regulate migration and autophagy energy of breast cancer cells, and further reveal that knockdown of GNB2 expression can activate AKT–mTOR pathway.58